Comparison between Prediabetes Defined by Hemoglobin A1c (A1C) 5.7-6.4% and that Defined by Impaired Fasting Glucose (IFG) in a Japanese Population

被引:1
作者
Suzuki, Hiroshi [1 ]
Oda, Eiji [2 ]
Aizawa, Yoshifusa [3 ]
机构
[1] Tachikawa Med Ctr, Dept Internal Med, Nagaoka, Niigata, Japan
[2] Tachikawa Med Ctr, Med Check Up Ctr, Nagachou 2-2-16, Nagaoka, Niigata 9400053, Japan
[3] Tachikawa Med Ctr, Dept Res & Dev, Nagaoka, Niigata, Japan
关键词
Prediabetes; Hemoglobin A1c; Impaired fasting glucose; HDL cholesterol; Total bilirubin;
D O I
10.4172/2155-6156.1000153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate prevalence and cardiovascular risk profiles of prediabetes defined by hemoglobin A1c (A1C) 5.7-6.4% and that defined by impaired fasting glucose (IFG) in Japanese. Subjects and Methods: We calculated the prevalence of isolated A1C 5.7-6.4%, isolated IFG, and overlap of A1C 5.7-6.4% and IFG and compared cardiovascular risk profiles of each group in non-diabetic Japanese 2,274 men and 1,417 women. Results: The prevalence of isolated A1C 5.7-6.4%, isolated IFG, and their overlapping was 6.1%, 11.9%, and 9.5%, respectively in men and 13.3%, 4.0%, and 6.4%, respectively in women. HDL cholesterol (p=0.004 in men and 0.03 in women), systolic blood pressure (p=0.047 in men and 0.0005 in women), and total bilirubin (p=0.0001 in men and 0.013 in women) were significantly lower in subjects with isolated A1C 5.7-6.4% compared with those with isolated IFG. Conclusions: Overlap of A1C 5.7-6.4% and IFG was not uncommon in Japanese. There were gender differences in the prevalence of isolated A1C 5.7-6.4% and isolated IFG. A1C 5.7-6.4% was associated with lower HDL cholesterol and lower bilirubin.
引用
收藏
页数:4
相关论文
共 18 条
  • [11] Bilirubin Is Negatively Associated With Hemoglobin A1c Independently of Other Cardiovascular Risk Factors in Apparently Healthy Japanese Men and Women
    Oda, Eiji
    Kawai, Ryu
    [J]. CIRCULATION JOURNAL, 2011, 75 (01) : 190 - 195
  • [12] Pani LN, 1991, DIABETES CARE, V31
  • [13] Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease - National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
    Perlstein, Todd S.
    Pande, Reena L.
    Beckman, Joshua A.
    Creager, Mark A.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (01) : 166 - 172
  • [14] Limited Overlap Between Intermediate Hyperglycemia as Defined by A1C 5.7-6.4%, Impaired Fasting Glucose, and Impaired Glucose Tolerance
    Saukkonen, Tuula
    Cederberg, Henna
    Jokelainen, Jari
    Laakso, Mauri
    Harkonen, Pirjo
    Keinanen-Kiukaanniemi, Sirkka
    Rajala, Ulla
    [J]. DIABETES CARE, 2011, 34 (10) : 2314 - 2316
  • [15] SCHWERTNER HA, 1994, CLIN CHEM, V40, P18
  • [16] Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults.
    Selvin, Elizabeth
    Steffes, Michael W.
    Zhu, Hong
    Matsushita, Kunihiro
    Wagenknecht, Lynne
    Pankow, James
    Coresh, Josef
    Brancati, Frederick L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (09) : 800 - 811
  • [17] BILIRUBIN IS AN ANTIOXIDANT OF POSSIBLE PHYSIOLOGICAL IMPORTANCE
    STOCKER, R
    YAMAMOTO, Y
    MCDONAGH, AF
    GLAZER, AN
    AMES, BN
    [J]. SCIENCE, 1987, 235 (4792) : 1043 - 1046
  • [18] Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)
    Troughton, Judith A.
    Woodside, Jayne V.
    Young, Ian S.
    Arveiler, Dominique
    Amouyel, Philippe
    Ferreires, Jean
    Ducimeteire, Pierre
    Patterson, Chris C.
    Kee, Frank
    Yarnell, John W. G.
    Evans, Alun
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (01): : 79 - 84